Business Wire
14 Aug 2026, 23:47 UTC · 4w ago
Verdict
Headline takes no side. We score AARD −0.80 across one claim — strongly bearish.
−0.80strongly bearish
More negative than 87% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish
A class action lawsuit has been filed against Aardvark Therapeutics (NASDAQ: AARD) by shareholders who acquired stock between February 13, 2025, and May 14, 2026.
More negative than 91% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 87% of ticker scores this week
The company is facing a class action lawsuit related to its IPO and subsequent securities offerings.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
7h ago
—
No price for AARD right now — the quote feed didn't answer.
AARD chart →
